Key considerations in the pharmacotherapy of tuberculous meningitis.
File(s)TBM therapy review_AM.pdf (249.33 KB)
Accepted version
Author(s)
Wasserman, Sean
Davis, Angharad
Wilkinson, Robert J
Meintjes, Graeme
Type
Journal Article
Date Issued
2019-07-14
Date Acceptance
2019-06-28
Citation
Expert Opinion on Pharmacotherapy, 20 (15), pp.1791-1795
ISSN
1465-6566
Publisher
Taylor & Francis
Start Page
1791
End Page
1795
Journal / Book Title
Expert Opinion on Pharmacotherapy
Volume
20
Issue
15
Copyright Statement
© 2019 Taylor & Francis. This is an Accepted Manuscript of an article published by Taylor & Francis in Expert Opinion on Pharmacotherapy on 15 July 2019, available online: https://doi.org/10.1080/14656566.2019.1638912
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/31305179
Subjects
Aspirin
Corticosteroids
Host-directed therapies
Linezolid
Rifampicin
Thalidomide
Tuberculous meningitis
Publication Status
Published online
Coverage Spatial
England
Date Publish Online
2019-07-15